While Semaglutide is primarily used for type 2 diabetes and obesity, and Wellbutrin for depression and smoking cessation, their combined use underscores a holistic approach to patient care, particularly for individuals who suffer from overlapping conditions such as obesity, diabetes, and depression
Switch medications If your prior authorization for Ozempic is denied or you dont have insurance, ask your healthcare provider about cheaper alternatives to Ozempic
However, Novo might have a few tricks up its sleeve, as its experimental obesity drug Amycretin could potentially surpass Wegovy and is set to start phase 3 trials in 2026
One of the things that we are seeing, obviously, is a dramatic shift in the basket of folks that are switching to a GLP-1 solution, Gosch said during a Midwinter panel discussion